Stockreport

institutional investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) must be disappointed after last week's 20% drop [Yahoo! Finance]

Neumora Therapeutics, Inc.  (NMRA) 
PDF 54% of the business is held by the top 4 shareholders Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a sto [Read more]